We present a method for measuring ascorbic acid in methanol/trichloroacetic acid extracts prepared from human plasma after enzymatic oxidation of ascorbic acid to dehydroascorbic acid by ascorbate oxidase. Samples were assayed by spectrophotometrically monitoring the kinetics of the concentration-dependent absorbance changes of dehydroascorbic acid with phosphate-citrate-methanol buffers. Ascorbic acid was determined as the difference between dehydroascorbic acid and total ascorbic acid content. The detection limit was <0.5 p.mol/L. The calibration curve was linear (r >0.995) over the range 0-1000 mol/L. Analytical recovery of ascorbic acid added to plasma was 93-105%. The between-day variance was <7%. Comparison of the spectrophotometric determination (y) with a chromatographic procedure (x) gave y = 1.02x -0.653 (Syb, = 3.61) over the range of physiologically relevant concentrations. Total analysis time is <10 mm per sample and allows the simultaneous analysis of multiple samples.
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Ascorbic acid is of great importance in biochemical reactions as a reducing agent. For example, recycling of antioxidants such as vitamin E by ascorbic acid has been shown to be protective against oxidative stress (1) . Numerous ascorbic acid assays have been applied for determining the physiological roles of the vitamin. Spectrophotometric procedures include the oxidation of ascorbic acid with 2,6-dichloroindophenol, the reduction of dehydroascorbic acid with 2,4-dinitrophenylhydrazine, or the reduction of metal ions to form lightabsorbing derivatives. These assays lack sensitivity and specificity because of interfering compounds such as sugars, amino acids, and glucuronic acid. Such disadvantages make them unattractive for use with cells, subcellular organelles, or plasma (2) .
Because of these problems, HPLC techniques have been developed to determine ascorbic acid. Unfortunately, ultraviolet detection is also subject to interference by other absorbing substances present in the sample, e.g., uric acid, hypoxanthine, or xanthine. Electrochemical detection provides better specificity, but both methods have to deal with the instability of ascorbic acid during the long time needed for sample analysis, especially when automated sampling devices are used. Elsewhere we have described a procedure that facilitates the direct measurement of dehydroascorbic acid in human plasma by spectrophotometrically monitoring the concentration-dependent kinetics of the absorbance changes of dehydroascorbic acid in phosphate! methanol-containing solutions (3). The method allows multiple sample analysis and avoids time-consuming sample processing. The reaction produces a mixture of ketals by adding methanol to the carbonyl groups in position 2 and 3 of dehydroascorbic acid (4). Here we describe the application of this spectrophotometric pro#{232}edure to determine ascorbic acid after its enzymatic oxidation to dehydroascorbic acid by ascorbate oxidase, calculating the ascorbic acid concentration as the difference between initial dehydroascorbic acid and total ascorbic acid concentrations. was set to 365 nm excitation and 418 nm emission with 15-nm slit bandpass. Under these conditions the fluorescent derivative was eluted after 7 mm. HPLC determination of ascorbic acid with ultraviolet detection was done with a modified ion-pair reversedphase technique, as described previously (6), also with a 5-sm (particle size) Sephasil C18 column, 250 X 4.6 mm. The mobile phase consisted of two buffers: 4 mmol/L tetrabutylammonium hydroxide, 10 mmol/L KH2PO4, and 10 mJJL methanol, pH 6.5 (buffer A); and 1.4 mmol/L tetrabutylammonium hydroxide, 10 mmol/L KH2PO4, and 300 mIlL methanol, pH 5.5 (buffer B). Buffers were filtered (0.2-sm pore-size filters) and analysis was performed by gradient separation: 5 mm at 1000 milL buffer A, 2 mm increasing to 400 mLfL buffer B, 9 mm increasing to 440 mLIL buffer B, 10 mm increasing to 1000 mLIL buffer B, and held there for 10 min. The flow rate was set to 1.2 mL/min, and absorbance was detected at 266 nm. Derivatization procedure.
Materials and Methods

Reagents.
Ascorbate oxidase (250 U) was dissolved in 2.5 mL of glycerol plus 2.5 mL of a 100 mmolIL monopotassium phosphate solution adjusted to pH 6; divided into portions;
and stored at -80 #{176}C. Ascorbic acid calibrators were dissolved in water and used immediately, because ascorbic acid degrades spontaneously in aqueous solutions.
To 800 L of ascorbic acid calibrators or samples we added 20 L of ascorbic acid oxidase solution and let this react for 5 mm at room temperature.
During this period ascorbic acid was completely oxidized as we determined previously. Methanol (400 L) and 700 g/L trichioroacetic acid solution (40 .tL) were added separately for protein precipitation.
The samples were cooled on ice and centrifuged at 10 000g for 10 mm at 4 #{176}C; 800 pi of the supernate was aspirated. Before analysis, 20 L of a freshly prepared 200 mmol/L desferrioxamine solution was added; the samples were then neutralized by adding 20 L of a 4 molIL potassium hydroxide solution. A double-Chelexed solution (200 L) containing 2 moIIL monosodiurfi phosphate and 0.333 mol/L citric acid 1-hydrate adjusted to pH 7.5 was added. Absorbance changes were monitored at 346 nm and 37 #{176}C. Samples and calibrators for dehydroascorbic acid determination were treated as described above except that ascorbic acid oxidase was replaced by distilled water.
Human plasma samples. 
Data analysis.
Each experimental result as shown in the figures is the mean ± SD for at least three measurements.
Results
Optimum assay conditions.
The dependence of the absorbance changes on the concentration of methanol, phosphate, and pH has been described previously (3).
The kinetics increase linearly with the methanol concentration but show a saturable maximum for increasing phosphate concentrations. The rate of absorbance changes increases up to pH 8; no absorbance change was detectable at higher pH values. The temperature dependence of the reaction kinetics is shown in Fig. 1 
Methods.
Typical calibration curves of formation rate against ascorbic acid concentrations in the ranges 0-100 mo1/L and 0-1000 mol/L are shown in Fig. 2 . The response to various concentrations of ascorbic acid was linear up to 1000 moVL ascorbic acid (r >0.995).
The reaction was followed for 300 s; the absorbance (n = 18); this decreased to nearly 0 after several freezing and thawing cycles, which have been described to convert ascorbic acid to dehydroascorbic acid (7). Five freezing and thawing cycles reduced the ascorbic acid content to <10% of the initial amount. Analytical recovery from biological samples. Human plasma samples were supplemented with different amounts of ascorbic acid to determine the extent of ascorbic acid recovery using this assay. All extracts showed virtually complete ascorbic acid recovery (Table 1), and the correlation of ascorbic acid added with ascorbic acid recovered was linear (r >0.999).
Assay specificity.
Human plasma samples were analyzed for ascorbic acid by oxidation of ascorbic acid by ascorbate oxidase, either spectrophotometrically as de- 
Stability.
The instability of ascorbic acid is the main problem of ascorbic acid or dehydroascorbic acid assays. Sufficient stability of ascorbic acid, both interand intraassay, is a prerequisite to avoid overestimating dehydroascorbic acid and underestimating ascorbic acid. To assess the interassay stability of ascorbic acid, we stored samples and calibrators at room temperature (25 #{176}C) and at 4 #{176}C, -20 #{176}C, and -80 #{176}C after the addition of methanol and trichloroacetic acid, as described in Materials and Methods. No loss of ascorbic acid was detectable in human plasma samples for 24 h at 4#{176}C or during 4 weeks when stored at -80 #{176}C (Fig.  4 ). Samples were stable at room temperature for 60 mm (100.8% ± 2.5% of the ascorbic acid concentration) but decreased to 71.7% ± 12.4% of the initial amount within 24 h. Stored at -20 #{176}C, samples contained 110% ± 7.3% of the initial ascorbic acid value after 2 weeks and 64.5% ± 2.6% after 4 weeks.
The intraassay stability of ascorbic acid was investigated by incubating 100 moI/L ascorbic acid calibrators under assay conditions. The absorbance changes at 346 nm, indicating the conversion of ascorbic acid to dehydroascorbic acid during the assay, were monitored. Trace metal complexing reagents have been .tmoVL AA, spectrophotometric method Without the addition of a trace metal complexing reagent, there was a constant loss of ascorbic acid under assay conditions, which was only slightly influenced by albumin, as shown in Table 2 . The addition of desferrioxamine prevented ascorbic acid from undergoing conversion to dehydroascorbic acid in a dose-dependent manner, and EDTA accelerated the ascorbic acid degradation over that in a solution containing no chelator, as reported previously (3). We were able to stabilize the ascorbic acid by removing trace metals with double-Chelexed phosphate-citrate solutions and adding 4 mmolJL desferrioxamine.
The residual absorbance changes reflect impurities of the ascorbic acid calibrator, as revealed by HPLC (data not shown). Intraassay stability was also determined for three plasma samples and gave similar results when compared with the calibrators, as shown in Table 2 . Precision data. To determine the precision of this assay, we estimated the ascorbic acid content of a pooled sample (nominally 24 moI/L) six times in succession for six consecutive days. Human plasma extracts were prepared as described in Materials and Methods and the methanol-trichloroacetic acid extracts were stored at -80 #{176}C. The within-day variance was calculated as the mean of the variances obtained for each day. The between-day variance was estimated by determining the variance of the daily means. The within-assay CV was 4.6% (23.9 ± 1.10 p.molfL), the between-assay CV 6.8% (23.9 ± 1.63 mo1/L), and the total CV was 8.2% (23.9 ± 1.96 moI/L).
Discussion
The method we describe determines the ascorbic acid content of human plasma samples as the difference between two measurements with and without oxidation of ascorbic acid, by spectrophotometrically monitoring the concentration-dependent absorbance changes of dehydroascorbic acid with phosphate-methanol solutions. The spectrophotometric equipment is easy to use, and sample preparation time is short. Multicell cuvette holders allow simultaneous spectrophotometric determinations of numerous samples. By obviating the time-consuming sample preparation required for most HPLC assays and using a high sampling rate, costs per sample are reduced. The interassay stability of ascorbic acid and the short time needed for sample preparation and analysis improve the reliability of this ascorbic acid assay.
The derivatization procedure is also easy to perform and avoids another problem of HPLC assays by stabilizing the ascorbic acid during the time needed to assay multiple samples. The interassay stability provided by this spectrophotometric assay allows large-scale analyses of numerous samples.
Trace metal residues in the reaction mixture can be reduced by using double-Chelexed buffers and by adding desferrioxamine, a potent iron chelator that prevents the reduction of iron by ascorbic acid with the concomitant formation of hydroxyl radicals, which perpetuate the loss of ascorbic acid. The enhancement of trace metal-induced peroxidative processes by EDTA has been described (9), and the EDTA-induced ascorbic acid degradation in phosphate-citrate buffers is in concordance with our previous results (3).
The reaction product was identified as a mixture of ketals by use of fast atom bombardment mass spectrometry in a sodium chloride-glycerol matrix, with a methyl diketal being the main reaction product. Further mass spectrometric analyses could not confirm this structure of the reaction product (molecular mass of 266 Da) because mass spectrometric peaks with an m/z ratio of 267 (MH) can be found even without the addition of the dehydroascorbic acid derivative and might result from the interaction of glycerol with sodium ions. Moreover, the dehydroascorbic acid derivative to the matrix does not result in an increase of the parent molecular ion (unpublished observations). Fur-ther analyses must be done to validate the proposed structure. We compared the spectrophotometric determination of ascorbic acid with a chromatographic procedure with fluorescence detection to assess the specificity of our assay. 
